Cargando…

Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential

Serous endometrial cancer (SEC) and high grade serous ovarian cancer (HGSOC) are aggressive gynecological malignancies with high rates of metastasis and poor prognosis. Endometrial intraepithelial carcinoma (EIC), the precursor for SEC, and serous tubal intraepithelial carcinoma (STIC), believed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Acland, Mitchell, Arentz, Georgia, Mussared, Max, Whitehead, Fergus, Hoffmann, Peter, Klingler-Hoffmann, Manuela, Oehler, Martin K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771701/
https://www.ncbi.nlm.nih.gov/pubmed/33384952
http://dx.doi.org/10.3389/fonc.2020.523989
_version_ 1783629724658958336
author Acland, Mitchell
Arentz, Georgia
Mussared, Max
Whitehead, Fergus
Hoffmann, Peter
Klingler-Hoffmann, Manuela
Oehler, Martin K.
author_facet Acland, Mitchell
Arentz, Georgia
Mussared, Max
Whitehead, Fergus
Hoffmann, Peter
Klingler-Hoffmann, Manuela
Oehler, Martin K.
author_sort Acland, Mitchell
collection PubMed
description Serous endometrial cancer (SEC) and high grade serous ovarian cancer (HGSOC) are aggressive gynecological malignancies with high rates of metastasis and poor prognosis. Endometrial intraepithelial carcinoma (EIC), the precursor for SEC, and serous tubal intraepithelial carcinoma (STIC), believed to be the precursor lesion for HGSOC, can also be associated with intraabdominal spread. To provide insight into the etiology of these precancerous lesions and to explore the potential molecular mechanisms underlying their metastatic behavior, we performed a proteomic mass spectrometry analysis in a patient with synchronous EIC and STIC. Through histological and molecular identification of precancerous lesions followed by laser capture microdissection, we were able to identify over 450 proteins within the precancerous lesions and adjacent healthy tissue. The proteomic analysis of STIC and EIC showed remarkable overlap in the proteomic patterns, reflecting early neoplastic changes in proliferation, loss of polarity and attachment. Our proteomic analysis showed that both EIC and STIC, despite being regarded as premalignant lesions, have metastatic potential, which correlates with the common presentation of invasive serous gynecological malignancies at advanced stage.
format Online
Article
Text
id pubmed-7771701
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77717012020-12-30 Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential Acland, Mitchell Arentz, Georgia Mussared, Max Whitehead, Fergus Hoffmann, Peter Klingler-Hoffmann, Manuela Oehler, Martin K. Front Oncol Oncology Serous endometrial cancer (SEC) and high grade serous ovarian cancer (HGSOC) are aggressive gynecological malignancies with high rates of metastasis and poor prognosis. Endometrial intraepithelial carcinoma (EIC), the precursor for SEC, and serous tubal intraepithelial carcinoma (STIC), believed to be the precursor lesion for HGSOC, can also be associated with intraabdominal spread. To provide insight into the etiology of these precancerous lesions and to explore the potential molecular mechanisms underlying their metastatic behavior, we performed a proteomic mass spectrometry analysis in a patient with synchronous EIC and STIC. Through histological and molecular identification of precancerous lesions followed by laser capture microdissection, we were able to identify over 450 proteins within the precancerous lesions and adjacent healthy tissue. The proteomic analysis of STIC and EIC showed remarkable overlap in the proteomic patterns, reflecting early neoplastic changes in proliferation, loss of polarity and attachment. Our proteomic analysis showed that both EIC and STIC, despite being regarded as premalignant lesions, have metastatic potential, which correlates with the common presentation of invasive serous gynecological malignancies at advanced stage. Frontiers Media S.A. 2020-12-15 /pmc/articles/PMC7771701/ /pubmed/33384952 http://dx.doi.org/10.3389/fonc.2020.523989 Text en Copyright © 2020 Acland, Arentz, Mussared, Whitehead, Hoffmann, Klingler-Hoffmann and Oehler http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Acland, Mitchell
Arentz, Georgia
Mussared, Max
Whitehead, Fergus
Hoffmann, Peter
Klingler-Hoffmann, Manuela
Oehler, Martin K.
Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
title Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
title_full Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
title_fullStr Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
title_full_unstemmed Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
title_short Proteomic Analysis of Pre-Invasive Serous Lesions of the Endometrium and Fallopian Tube Reveals Their Metastatic Potential
title_sort proteomic analysis of pre-invasive serous lesions of the endometrium and fallopian tube reveals their metastatic potential
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771701/
https://www.ncbi.nlm.nih.gov/pubmed/33384952
http://dx.doi.org/10.3389/fonc.2020.523989
work_keys_str_mv AT aclandmitchell proteomicanalysisofpreinvasiveserouslesionsoftheendometriumandfallopiantuberevealstheirmetastaticpotential
AT arentzgeorgia proteomicanalysisofpreinvasiveserouslesionsoftheendometriumandfallopiantuberevealstheirmetastaticpotential
AT mussaredmax proteomicanalysisofpreinvasiveserouslesionsoftheendometriumandfallopiantuberevealstheirmetastaticpotential
AT whiteheadfergus proteomicanalysisofpreinvasiveserouslesionsoftheendometriumandfallopiantuberevealstheirmetastaticpotential
AT hoffmannpeter proteomicanalysisofpreinvasiveserouslesionsoftheendometriumandfallopiantuberevealstheirmetastaticpotential
AT klinglerhoffmannmanuela proteomicanalysisofpreinvasiveserouslesionsoftheendometriumandfallopiantuberevealstheirmetastaticpotential
AT oehlermartink proteomicanalysisofpreinvasiveserouslesionsoftheendometriumandfallopiantuberevealstheirmetastaticpotential